Zhitong Financial App News, Boan Biotech (06955.HK) announced that the company's marketing license application for abacip intraocular injection solution (BA9101) has been submitted to Brazil's National Health Administration (ANVISA) to treat neovascularization (wet) age-related macular degeneration (NaMD) and diabetic macular edema (DME) in adults.

Zhitongcaijing · 1d ago
Zhitong Financial App News, Boan Biotech (06955.HK) announced that the company's marketing license application for abacip intraocular injection solution (BA9101) has been submitted to Brazil's National Health Administration (ANVISA) to treat neovascularization (wet) age-related macular degeneration (NaMD) and diabetic macular edema (DME) in adults.